Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 1998

View Archived Issues

Chiroscience discloses new MMP/TNF inhibitors

Tanabe Seiyaku patents new ACAT and lipid peroxidation inhibitors

Taiho describes compounds for post-PTCA restenosis

Fujisawa isolates new agent for influenza

Progenics reports new insights into HIV binding mechanisms

Potential new application for lamotrigine in Lennox-Gastaut syndrome?

New CNS growth factor identified by Boston Life Sciences collaborators

Warner-Lambert develops new ET antagonists

SKB reports prodrugs of 5-HT2C receptor antagonists

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Bristol-Myers Squibb prepares melatonergic agents

Drug discovery collaboration established by Aurora and Merck

PLC Systems submits requested data related to Heart Laser PMA

Faulding establishes new U.S. division, regains rights to Kadian

FDA clears new Allegra product; Seldane to be withdrawn

Antitussive properties of Chinoin xanthine explored

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Cell Genesys to receive milestone payment from HMR for GA-EPO

NIH contemplates licensing ophthalmic technology to GenVec

Theratechnologies to begin clinical testing of leukemia Rx

Astra to launch new tablet formulation of Losec in Sweden

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

ABX-CBL evaluated in phase II GVHD trial

U.S. Bioscience signs CRADA for novel AIDS drug

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

NDA filed for betamethasone mousse

Photofrin approval sought in nine additional European countries

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...